Patients Show Nearly Two-fold Clinical Improvement when Treatment Selection Informed by PrismRA; Predictive Blood Test Could Improve Efficiency in Health Care Spending WALTHAM, Mass. (April 28, 2022) – Scipher Medicine, a precision immunology company matching...
WALTHAM, Mass. (Feb. 28, 2022) – Scipher Medicine, a precision immunology company matching each patient with their most effective therapy, today announced Chief Technology Officer Slava Akmaev, Ph.D., will participate in a virtual panel at the Truist Securities...
WALTHAM, Mass. (Feb. 11, 2022) – Scipher Medicine, a precision immunology company matching each patient with their most effective therapy, today announced that Chief Financial Officer John Strumbos will participate in the virtual 11th Annual SVB Leerink...
Patient Response to Treatment 3x Better When PrismRA Guided Therapy Selection Test Results Informed Treatment Decisions for Three-Quarters of Patients Broad Adoption Could Lead to Significant Clinical Improvements for Rheumatoid Arthritis Patients WALTHAM, Mass. (Feb....
WALTHAM, Mass. (Jan. 6, 2022) - Scipher Medicine, a precision immunology company matching each patient with their most effective therapy, today announced that Alif Saleh, chief executive officer, will present at the 40th Annual J.P. Morgan...
